Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maho Ashikawa"'
Autor:
Masami Suzuki, Fumiko Chiwaki, Yumi Sawada, Maho Ashikawa, Kazuhiko Aoyagi, Takeshi Fujita, Kazuyoshi Yanagihara, Masayuki Komatsu, Minoru Narita, Tsutomu Suzuki, Hiroshi Nagase, Ryoji Kushima, Hiromi Sakamoto, Takeo Fukagawa, Hitoshi Katai, Hitoshi Nakagama, Teruhiko Yoshida, Yasuhito Uezono, Hiroki Sasaki
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123407 (2015)
The dormancy of tumor cells is a major problem in chemotherapy, since it limits the therapeutic efficacy of anti-tumor drugs that only target dividing cells. One potential way to overcome chemo-resistance is to "wake up" these dormant cells. Here we
Externí odkaz:
https://doaj.org/article/0ea575147661431498c338d3c2f83e28
Autor:
Maho Ashikawa, Tsutomu Suzuki, Hiroki Sasaki, Sadayoshi Furuta, Kazuyoshi Yanagihara, Motohiro Matoba, Kiyoshi Terawaki, Minoru Narita, Masami Suzuki, Yasuhito Uezono
Publikováno v:
Synapse. 66:747-751
Autor:
Motohiro Matoba, Minoru Narita, Sadayoshi Furuta, Masami Suzuki, Kazuyoshi Yanagihara, Yasuhito Uezono, Tsutomu Suzuki, Fumiko Chiwaki, Kanako Miyano, Maho Ashikawa, Hiroki Sasaki, Minami Hasegawa, Takahiro Ochiya, Tomoyuki Kawamata
Publikováno v:
Anesthesiology. 117(4)
Background Patients with peritoneal carcinomatosis often report abdominal pain, which is relatively refractory to morphine. It has been considered that a new animal model is required to investigate the mechanism of abdominal pain for the development
Autor:
Hiroki Sasaki, Fumiko Chiwaki, Minoru Narita, Takeo Fukagawa, Hiroshi Nagase, Masami Suzuki, Hitoshi Katai, Hitoshi Nakagama, Takeshi Fujita, Masayuki Komatsu, Maho Ashikawa, Teruhiko Yoshida, Yumi Sawada, Yasuhito Uezono, Hiromi Sakamoto, Ryoji Kushima, Tsutomu Suzuki, Kazuhiko Aoyagi, Kazuyoshi Yanagihara
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123407 (2015)
PLoS ONE
PLoS ONE
The dormancy of tumor cells is a major problem in chemotherapy, since it limits the therapeutic efficacy of anti-tumor drugs that only target dividing cells. One potential way to overcome chemo-resistance is to "wake up" these dormant cells. Here we